Private Advisory Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,648
| Closed | -$487K | – | 226 |
|
|
2024
Q4 | $487K | Sell |
5,648
-72
| -1% | -$6.21K | 0.05% | 149 |
|
|
2024
Q3 | $544K | Sell |
5,720
-32,274
| -85% | -$3.07M | 0.06% | 141 |
|
|
2024
Q2 | $3.48M | Buy |
37,994
+128
| +0.3% | +$11.7K | 0.45% | 57 |
|
|
2024
Q1 | $3.43M | Sell |
37,866
-1,670
| -4% | -$151K | 0.49% | 61 |
|
|
2023
Q4 | $3.22M | Buy |
39,536
+1,258
| +3% | +$102K | 0.56% | 49 |
|
|
2023
Q3 | $3.06M | Buy |
38,278
+127
| +0.3% | +$10.1K | 0.6% | 45 |
|
|
2023
Q2 | $3.01M | Buy |
+38,151
| New | +$3.01M | 0.6% | 43 |
|